CytomX Therapeutics (CTMX) Reports FY18 Loss of $2.03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 2.20 +0.02 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.18 | 52 Week High | $24.68 | |||
| Open | $2.26 | 52 Week Low | $9.10 | |||
| Day High | $2.28 | P/E | N/A | |||
| Day Low | $2.18 | EPS | $0.00 | |||
| Volume | 942,445 | |||||
